VP Manufacturing The VP Manufacturing will provide strategic, operational, and technical leadership for the companys manufacturing activities supporting late-stage clinical development, commercial readiness, and future commercial supply of the companys lead biologic programs, including SAB?142. This role
VP of Quality Assurance The VP of Quality Assurance (VP QA) is a key executive leader responsible for building, scaling, and overseeing SABs global Quality Assurance organization as the company advances from late-stage clinical development toward
Vice-President Regulatory Affairs The Vice-President Regulatory Affairs is responsible for ensuring that compliance is being upheld for Regulatory Affairs at SAB Biotherapeutics (SAB). This role will lead preparation, review and submission of documents to FDA and
The Vice President Regulatory Affairs (RA) is responsible for ensuring that compliance is being upheld for Regulatory Affairs at SAB Biotherapeutics (SAB). This role will lead preparation, review and submission of documents to FDA and ex-US
The VP Manufacturing will provide strategic, operational, and technical leadership for the company’s manufacturing activities supporting late-stage clinical development, commercial readiness, and future commercial supply of the company’s lead biologic programs, including SAB‑142. This role is responsible
The VP Manufacturing will provide strategic, operational, and technical leadership for the company’s manufacturing activities supporting late-stage clinical development, commercial readiness, and future commercial supply of the company’s lead biologic programs, including SAB‑142. This role is responsible
The Vice President Regulatory Affairs (RA) is responsible for ensuring compliance is being upheld for Regulatory Affairs at SAB Biotherapeutics (SAB). This role will lead preparation, review and submission of documents to FDA and ex-US health
The Sr. Director, Medical Writing – Biologics will provide strategic and operational leadership for the preparation, development, and delivery of high-quality regulatory and clinical documents supporting the late-stage development and anticipated commercialization of SAB’s lead biologic